Advertisement

Outcomes of First- Versus Second-Generation Drug-Eluting Stent Implanted for Right Coronary Artery Ostial Narrowing

Published:December 17, 2016DOI:https://doi.org/10.1016/j.amjcard.2016.11.038
      Clinical outcome is generally poor when stents are implanted at right coronary artery ostial lesion (RCAos). We compared the clinical outcome between the first-generation drug-eluting stent (first DES) and second-generation drug-eluting stent (second DES) used for RCAos. Consecutive 88 patients who underwent percutaneous coronary interventions of de novo RCAos using the first DES (33 patients) or second DES (55 patients) were analyzed. The incidence of major adverse cardiac events (MACE) defined as the composite of cardiac death, myocardial infarction attributed to right coronary artery, and target lesion revascularization within 2.5 years was compared. The incidence of MACE was significantly lower in second DES (11% vs 36%, p = 0.010) than that in the first DES. Multivariate analysis revealed use of second DES (odds ratio 0.24, 95% CI 0.11 to 0.93, p = 0.008) alone was significantly associated with MACE. In conclusion, second DES revealed better clinical outcome than the first DES when used in de novo RCAos.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Iakovou I.
        • Ge L.
        • Michev I.
        • Sangiorgi G.
        • Montorfano M.
        • Airoldi F.
        • Chieffo A.
        • Stankovic G.
        • Vitrella G.
        • Carlino M.
        • Corvaja N.
        • Briguori C.
        • Colombo A.
        Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions.
        J Am Coll Cardiol. 2004; 44: 967-971
        • Sakamoto H.
        • Ishikawa T.
        • Mutoh M.
        • Imai K.
        • Mochizuki S.
        Angiographic and clinical outcomes after sirolimus-eluting stent implantation to de novo ostial lesion of the right coronary artery -a retrospective study-.
        Circ J. 2008; 72: 880-885
        • Windecker S.
        • Stortecky S.
        • Stefanini G.G.
        • da Costa B.R.
        • Rutjes A.W.
        • Di Nisio M.
        • Silletta M.G.
        • Maione A.
        • Alfonso F.
        • Clemmensen P.M.
        • Collet J.P.
        • Cremer J.
        • Falk V.
        • Filippatos G.
        • Hamm C.
        • Head S.
        • Kappetein A.P.
        • Kastrati A.
        • Knuuti J.
        • Landmesser U.
        • Laufer G.
        • Neumann F.J.
        • Richter D.
        • Schauerte P.
        • Sousa Uva M.
        • Taggart D.P.
        • Torracca L.
        • Valgimigli M.
        • Wijns W.
        • Witkowski A.
        • Kolh P.
        • Jüni P.
        Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.
        BMJ. 2014; 348: g3859
        • Ko E.
        • Natsuaki M.
        • Toyofuku M.
        • Morimoto T.
        • Matsumura Y.
        • Oi M.
        • Motohashi Y.
        • Takahashi K.
        • Kawase Y.
        • Tanaka M.
        • Kitada M.
        • Yuzuki Y.
        • Tamura T.
        • Inoue K.
        • Mitsudo K.
        • Kimura T.
        Sirolimus-eluting stent implantation for ostial right coronary artery lesions: five-year outcomes from the j-Cypher registry.
        Cardiovasc Interv Ther. 2014; 29: 200-208
        • Lam M.K.
        • Sen H.
        • Tandjung K.
        • Löwik M.M.
        • Basalus M.W.
        • Mewes J.C.
        • Stoel M.G.
        • van Houwelingen K.G.
        • Linssen G.C.
        • Ijzerman M.J.
        • Doggen C.J.
        • von Birgelen C.
        Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial.
        Catheter Cardiovasc Interv. 2015; 85: 524-531
        • Topol E.J.
        • Ellis S.G.
        • Fishman J.
        • Leimgruber P.
        • Myler R.K.
        • Stertzer S.H.
        • O'Neill W.W.
        • Douglas J.S.
        • Roubin G.S.
        • King 3rd, S.B.
        Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis.
        J Am Coll Cardiol. 1987; 9: 1214-1218
        • Jain S.P.
        • Liu M.W.
        • Dean L.S.
        • Babu R.
        • Goods C.M.
        • Yadav J.S.
        • Al-Shaibi K.F.
        • Mathur A.
        • Iyer S.S.
        • Parks J.M.
        • Baxley W.A.
        • Roubin G.S.
        Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions.
        Am J Cardiol. 1997; 79: 1334-1338
        • Motwani J.G.
        • Raymond R.E.
        • Franco I.
        • Ellis S.G.
        • Whitlow P.L.
        Effectiveness of rotational atherectomy of right coronary artery ostial stenosis.
        Am J Cardiol. 2000; 85: 563-567
        • Applegate R.J.
        • Draughn T.
        • Yarbrough W.D.
        • Little W.C.
        Restenosis of a sirolimus drug-eluting stent: aorto-ostial involvement of the proximal right coronary artery.
        Catheter Cardiovasc Interv. 2006; 67: 391-395
        • Stewart J.T.
        • Ward D.E.
        • Davies M.J.
        • Pepper J.R.
        Isolated coronary ostial stenosis: observations on the pathology.
        Eur Heart J. 1987; 8: 917-920
        • Fujii K.
        • Carlier S.G.
        • Mintz G.S.
        • Yang Y.M.
        • Moussa I.
        • Weisz G.
        • Dangas G.
        • Mehran R.
        • Lansky A.J.
        • Kreps E.M.
        • Collins M.
        • Stone G.W.
        • Moses J.W.
        • Leon M.B.
        Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study.
        J Am Coll Cardiol. 2005; 45: 995-998
        • Park D.W.
        • Hong M.K.
        • Suh I.W.
        • Hwang E.S.
        • Lee S.W.
        • Jeong Y.H.
        • Kim Y.H.
        • Lee C.W.
        • Kim J.J.
        • Park S.W.
        • Park S.J.
        Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.
        Am J Cardiol. 2007; 99: 760-765
        • Luz A.
        • Hughes C.
        • Magalhães R.
        • Bisceglia T.
        • Descoutures F.
        • Tamamm K.
        • Tchetche D.
        • Sauguet A.
        • Farah B.
        • Fajadet J.
        Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome.
        EuroIntervention. 2012; 7: 1069-1076
        • Sianos G.
        • Hofma S.
        • Ligthart J.M.
        • Saia F.
        • Hoye A.
        • Lemos P.A.
        • Serruys P.W.
        Stent fracture and restenosis in the drug-eluting stent era.
        Catheter Cardiovasc Interv. 2004; 61: 111-116
        • Nakamura M.
        • Muramatsu T.
        • Yokoi H.
        • Okada H.
        • Ochiai M.
        • Suwa S.
        • Hozawa H.
        • Kawai K.
        • Awata M.
        • Mukawa H.
        • Fujita H.
        • Shiode N.
        • Asano R.
        • Tsukamoto Y.
        • Yamada T.
        • Yasumura Y.
        • Ohira H.
        • Miyamoto A.
        • Takashima H.
        • Ogawa T.
        • Matsuyama Y.
        • Nanto S.
        • J-DESsERT investigators
        Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT).
        Cardiovasc Interv Ther. 2015; 30: 103-114
        • Windecker S.
        • Remondino A.
        • Eberli F.
        • Jüni P.
        • Räber L.
        • Wenaweser P.
        • Togni M.
        • Billinger M.
        • Tüller D.
        • Seiler C.
        • Roffi M.
        • Corti R.
        • Sütsch G.
        • Maier W.
        • Lüscher T.
        • Hess O.
        • Egger M.
        • Meier B.
        Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
        N Engl J Med. 2005; 353: 653-662
        • Sidhu S.
        • Shafiq N.
        • Malhotra S.
        • Pandhi P.
        • Grover A.
        A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.
        Br J Clin Pharmacol. 2006; 61: 720-726
        • Natsuaki M.
        • Nakagawa Y.
        • Morimoto T.
        • Ono K.
        • Shizuta S.
        • Furukawa Y.
        • Kadota K.
        • Iwabuchi M.
        • Kato Y.
        • Suwa S.
        • Inada T.
        • Doi O.
        • Takizawa A.
        • Nobuyoshi M.
        • Kita T.
        • Kimura T.
        • CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators
        Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2).
        Am J Cardiol. 2012; 109: 1387-1396
        • Ueda Y.
        • Matsuo K.
        • Nishimoto Y.
        • Sugihara R.
        • Hirata A.
        • Nemoto T.
        • Okada M.
        • Murakami A.
        • Kashiwase K.
        • Kodama K.
        In-stent yellow plaque at 1 year after implantation is associated with future event of very late stent failure: the DESNOTE study (Detect the Event of Very Late Stent Failure from the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy).
        JACC Cardiovasc Interv. 2015; 8: 814-821